Sign up
Pharma Capital

Namaste Technologies addresses recent challenges as they look to grow in the future

Namaste Technologies (CVE:N) Interim CEO Meni Morim and Chief Strategies Officer Darren Gill joined Proactive Investor's Steve Darling from Toronto to provide a corporate update on Namaste after a series of corporate changes. Morim addressed the recent parting of ways with the company's auditors and what the focus of Namaste is going forward.

Gill told Proactive about their recent move in acquiring 49 percent of Choklat and how this first in to their new model at Namaste. 

 

View full N profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.